A practical reference on reversed-phase HPLC: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-08-01 and is reviewed periodically as new material appears.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
Early work on thymic extracts in the 1960s described a heat-stable acidic fraction containing many polypeptides. Separation of that mixture yielded individual components, and thymosin alpha-1 was named as one of them on the basis of assays for T-cell activity. The first preparations came from calf thymus, while subsequent research and clinical material has been chemically synthesized. Nomenclature in older papers is inconsistent, and the same peptide sometimes appears under different designations, which complicates literature searches.
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or chemically modified byproducts. Mass spectrometry confirms the expected molecular mass and can indicate acetylation state or sequence errors. Amino acid analysis and peptide mapping supply complementary sequence-level information, while endotoxin testing is relevant for preparations intended for cell or animal work. Purity figures reported by suppliers refer to the method used and are not directly comparable across laboratories unless conditions are stated.
Lyophilized material is typically treated as a hygroscopic solid that should be brought to room temperature before the container is opened, which limits condensation on the powder. Reconstitution is commonly done with sterile water or a buffered diluent, and gentle mixing is preferred over vigorous agitation to reduce foaming and surface adsorption. Because peptides can bind to plastic and glass, diluents containing a small amount of carrier protein are sometimes used in laboratory work. Working solutions are generally aliquoted and prepared fresh rather than subjected to repeated freezing and thawing.
The molar mass M(X) of atoms of an element X is given by the relative atomic mass Ar(X) of the element multiplied by the molar mass constant, Mu, which (for all practical purposes) is equal to 1 g/mol: M(X) = Ar(X) ⋅ Mu. For normal samples from Earth with typical isotope composition, the atomic weight can be approximated by the standard atomic weight or the conventional atomic weight.
Michael Howard Wigler (born September 3, 1947, in New York) is an American molecular biologist who has directed a laboratory at Cold Spring Harbor Laboratory since 1978 and is a member of the National Academy of Sciences. He is best known for developing methods to genetically engineer animal cells and his contributions to cancer, genomics and autism genetics.
== Measurement techniques == Standard organic geochemical methods are employed to prepare samples of dinosterol for analysis. Collected algae samples can be centrifuged and then lyophilized. A Bligh and Dyer extraction can then be performed to isolate the major lipid classes. Lipid samples are often derivatized with bis(trimethylsilyl)trifluoroacetamide (BSTFA) for gas chromatography-mass spectrometry (GC-MS) analysis.
The term pair bond originated in 1940 in reference to mated pairs of birds; referring to a monogamous or relatively monogamous relationship. Whilst some form of monogamy may characterise around 90% of bird species, in mammals long-term pairing (beyond the brief duration of copulation itself) is rare, at around 3% (see animal monogamy). The incidence of monogamy in primate species is similarly low in contrast with polygyny (one male mating with two or more females), the most common pattern. However, regardless of mating patterns, primate life is typically characterised by long-lasting social relationships (whether sexual, care-giving, coalitionary or otherwise) formed in the context of living in durable social groups, and any such durable relationship (whether exclusive or not) is characterised by some degree of bonding. Similarly, whilst the 'naturalness' of monogamy in humans is debated, durable monogamous or polygamous relationships will typically be accompanied by affectional or emotional bonding (see next section).
Sources: en.wikipedia.org
The brain is particularly vulnerable to chemicals that are able to cross the blood-brain barrier. Body-first and brain-first models of Parkinson's disease propose that there are two distinct avenues through which environmental toxicants can enter the nervous system: (1) ingested into the gut and affecting the enteric nervous system (body-first), or (2) inhaled through the nose and affecting the olfactory bulb (brain-first). The World Health Organization (WHO) recommends reducing exposure to environmental factors associated with PD, including pesticides, trichloroethylene (TCE), and air pollution. Traumatic brain injury and Type 2 diabetes are additional risk factors. Exercise, coffee consumption, and diets rich in fruits, vegetables, whole grains, and fish are protective factors associated with lower risk of PD.
Fibringogen storage disease is an extremely rare disorder. It is a form of congenital hypofibrinogenemia in which certain specific hereditary mutations in one copy of the FGG gene causes its fibrinogen product to accumulate in, and damage, liver cells. The disorder has not reported with FGA or FGB mutations. Symptoms of these FGG mutations have a low level of penetrance. The plasma fibrinogen levels (generally <150 but >50 mg/dl) detected in this disorder reflect the fibrinogen made by the normal gene. Fibrinogen storage disease may lead to abnormal bleeding and thrombosis but is distinguished by also sometimes leading to liver cirrhosis.
In Staphylococcus aureus, IMPDH have been identified as a plasminogen-binding protein. Drosophila IMPDH has been demonstrated to act as a sequence-specific transcriptional repressor that can reduce the expression of histone genes and E2F. IMPDH localizes to the nucleus at the end of the S phase and nuclear accumulation is mostly restricted to the G2 phase. In addition, metabolic stress has been shown to induce the nuclear localization of IMPDH.
During the later part of the 18th century, fundamental internal reforms were attempted in the Polish–Lithuanian Commonwealth as it slid into extinction. The reform activity, initially promoted by the magnate Czartoryski family faction known as the Familia, provoked a hostile reaction and military response from neighboring powers, but it did create conditions that fostered economic improvement. The most populous urban center, the capital city of Warsaw, replaced Danzig (Gdańsk) as the leading trade center, and the importance of the more prosperous urban social classes increased. The last decades of the independent Commonwealth's existence were characterized by aggressive reform movements and far-reaching progress in the areas of education, intellectual life, art and the evolution of the social and political system. The royal election of 1764 resulted in the elevation of Stanisław August Poniatowski, a refined and worldly aristocrat connected to the Czartoryski family, but hand-picked and imposed by Empress Catherine the Great of Russia, who expected him to be her obedient follower. Stanisław August ruled the Polish–Lithuanian state until its dissolution in 1795. The king spent his reign torn between his desire to implement reforms necessary to save the failing state and the perceived necessity of remaining in a subordinate relationship to his Russian sponsors. The Bar Confederation (1768–1772) was a rebellion of nobles directed against Russia's influence in general and Stanisław August, who was seen as its representative, in particular.
Cristalino [kɾistaˈlino] ("crystalline"): aged tequila that has been filtered to remove its color before bottling, similar to chill filtering of whisky Rosa ("pink"): a young version of the spirit "lightly aged in red wine barrels"
Sources: en.wikipedia.org
ATP + Creatine → H+ + ADP + CP (Mg2+ assisted, catalyzed by creatine kinase) ADP + Pi → ATP (during anaerobic glycolysis and oxidative phosphorylation) AMP can dephosphorylate to adenosine and diffuse out of the cell; the purine nucleotide cycle may therefore also reduce the loss of adenosine from the cell since nucleosides permeate cell membranes, whereas nucleotides do not.
=== Recurring === Eme Ikwuakor as Elijah, an attorney at Jacobson Moore who was in a romantic relationship with Olympia Beau Bridges as Howard "Senior" Markston, a managing partner at Jacobson Moore, father of Julian, and soon-to-be ex-father-in-law of Olympia. He guardedly supports Olympia's career and efforts to develop a new revenue stream for the firm, telling her how he believes being father-in-law is a forever role. Patricia Belcher as Mrs. B, an administrative manager at Jacobson Moore. It is later revealed her full name is Emmalyn Belvin. Yael Grobglas as Shae Banfield, a jury consultant at Jacobson Moore Piper Curda as Kira, a woman who works at the information technology (IT) department at Jacobson Moore who begins a relationship with Sarah Marnee Carpenter as Ellie Kingston, Matty and Edwin's deceased daughter and Alfie's mother, who appears in flashbacks Andrea Londo as Simone, a recently hired junior associate at Jacobson Moore who attended the same law school as Sarah Niko Nicotera as Joseph "Joey" Danza, Alfie's father who is a drug addict Justina Machado as Eva (season 2), Senior's fourth ex-wife who is also a lawyer and member of the executive committee at Jacobson Moore James Lesure as Lester "The Wolf" Logan (season 2) Justin Cornwell as Mr. Hodges (season 2), Olympia's love interest who is also a lawyer Sarah Wright Olsen as Gwen (season 2), a productivity consultant evaluating Jacobson Moore Henry Haber as Hunter (season 2), an eager new associate on Olympia's team
== Diagnosis == Research on prenatal diagnosis has shown that a diagnosis can be made prenatally in approximately 50% of fetuses presenting arthrogryposis. It could be found during routine ultrasound scanning showing a lack of mobility and abnormal position of the foetus. There are other options for visualization of details and structures using techniques such as 4D ultrasound. In clinic a child can be diagnosed with arthrogryposis with physical examination, confirmed by ultrasound, MRI, or muscle biopsy.
Concanavalin A (ConA) is a lectin (carbohydrate-binding protein) originally extracted from the jack-bean (Canavalia ensiformis). It is a member of the legume lectin family. It binds specifically to certain structures found in various sugars, glycoproteins, and glycolipids, mainly internal and nonreducing terminal α-D-mannosyl and α-D-glucosyl groups. Its physiological function in plants, however, is still unknown. ConA is a plant mitogen, and is known for its ability to stimulate mouse T-cell subsets giving rise to four functionally distinct T cell populations, including precursors to regulatory T cells; a subset of human suppressor T-cells is also sensitive to ConA. ConA was the first lectin to be available on a commercial basis, and is widely used in biology and biochemistry to characterize glycoproteins and other sugar-containing entities on the surface of various cells. It is also used to purify glycosylated macromolecules in lectin affinity chromatography, as well as to study immune regulation by various immune cells.
==== Jamaica ==== "Cow cod soup" is a traditional, rustic dish in Jamaican cuisine that is considered an aphrodisiac and made with bull penis ("cod"). It is traditionally cooked with bananas and Scotch bonnet peppers in a white rum-based broth.
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
Its sequence corresponds to the amino-terminal portion of prothymosin alpha, a larger protein present in many cell types. The isolated 28-residue peptide is a fragment of that protein rather than a separately encoded molecule, and laboratory material is produced by synthesis.